Riskpilot← Back to searchSign inGet full accessSwepox AB
ABActiveOrg 5592626229Cypressvägen 7Activities of advertising agencies · NACE 7311Est. 20200 employees
Revenue 2025
SEK 1,1M
+5454% vs 2024
EBITDA margin
70.4%
+4327% vs 2024
Equity ratio
54.6%
Financial strength
Net profit 2025
SEK 465K
+2624% vs 2024
| Revenue | SEK 1,1M | +5454% |
| EBITDA | SEK 778K | +4327% |
| Net profit | SEK 465K | +2624% |
| Total assets | SEK 835K | +3026% |
| Equity | SEK 456K | +2733% |
| Employees | 0 | — |
Legal name
Swepox AB
Org number
5592626229
Legal form
Aktiebolag
NACE code
7311 · Activities of advertising agencies
Founded
7 juli 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget erbjuder konsulttjänster inom hälsa och sjukvård, estetisk medicin samt djurvård. Vår verksamhet riktar sig till både privatpersoner och företag samt därmed förenlig verksamhet.
Address
Cypressvägen 7
Email
drneha@shapeby.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | — | — | 20 | 1 105 |
| Staff expenses | — | — | — | — | −7 |
| EBITDA | −5 | −5 | −6 | −18 | 778 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −5 | −5 | −6 | −18 | 778 |
| Net financials | — | — | — | — | 0 |
| Profit before tax | −5 | −5 | −6 | −18 | 584 |
| Tax | −0 | — | — | — | −120 |
| Net profit | −5 | −5 | −6 | −18 | 465 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 47 | 42 | 37 | 27 | 835 |
| Equity | 20 | 15 | 34 | 16 | 456 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 26 | 27 | 2 | 11 | 185 |
| Total debt | 26 | 27 | 2 | 11 | 185 |
EBITDA margin
70.4%
This company
15.8%
Market median
+346% vs market
20212025
Equity ratio
54.6%
This company
38.2%
Market median
+43% vs market
20212025
Return on equity
102.0%
This company
18.4%
Market median
+454% vs market
20212025
Net profit margin
42.0%
This company
8.1%
Market median
+419% vs market
20212025
Asset turnover
1.32×
This company
1.12×
Market median
+18% vs market
20212025
Debt / equity
0.83×
This company
0.62×
Market median
+34% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2024 | — | — | |
| Deputy Board Member | 2025 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2024 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Swepox AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Charlie Karl Joakim Ringenson | Chairman | 0 companies |
| Stevan Curcic | Board of Directors | 0 companies |
| Marko Sarcevic | Chairman | 0 companies |
| Ava Arpana Stark | Deputy Board Member | 0 companies |
| Milojko Sarcevic | Board of Directors | 0 companies |
| Neha Sarcevic | Board of Directors | 0 companies |